(Q48564189)

12 February 2018

title

Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. (English)

1 reference

12 February 2018

1 reference

21

1 reference

12 February 2018

Gema L Ramírez-Villar

Gema L Ramírez-Villar

14

0 references

Manfred Gessler

Manfred Gessler

18

0 references

Rhoikos Furtwängler

Rhoikos Furtwängler

5

0 references

Kathy Pritchard-Jones

3

Kathy Pritchard-Jones

1 reference

PubMed ID

29089605

Marry M van den Heuvel-Eibrink

12 February 2018

1

Marry M van den Heuvel-Eibrink

1 reference

12 February 2018

author name string

Janna A Hol

2

1 reference

12 February 2018

Harm van Tinteren

4

1 reference

12 February 2018

Arnauld C Verschuur

6

1 reference

12 February 2018

Gordan M Vujanic

7

1 reference

12 February 2018

Ivo Leuschner

8

1 reference

12 February 2018

Jesper Brok

9

1 reference

12 February 2018

Christian Rübe

10

1 reference

12 February 2018

Anne M Smets

11

1 reference

12 February 2018

Geert O Janssens

12

1 reference

12 February 2018

Jan Godzinski

13

1 reference

12 February 2018

Beatriz de Camargo

15

1 reference

12 February 2018

Heidi Segers

16

1 reference

12 February 2018

Paola Collini

17

1 reference

12 February 2018

Christophe Bergeron

19

1 reference

12 February 2018

Filippo Spreafico

20

1 reference

12 February 2018

International Society of Paediatric Oncology — Renal Tumour Study Group (SIOP–RTSG)

22

1 reference

12 February 2018

language of work or name

English

0 references

publication date

31 October 2017

1 reference

12 February 2018

published in

Nature Reviews Urology

1 reference

12 February 2018

volume

14

1 reference

12 February 2018

issue

12

1 reference

12 February 2018

page(s)

743-752

1 reference

12 February 2018

Creative Commons Attribution 4.0 International

copyright license

start time

31 October 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/nrurol.2017.163

0 references

cites work

Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Wilms' tumor: past, present and (possibly) future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Tumor biology influences the prognosis of nephroblastoma patients with primary pulmonary metastases: results from SIOP 93-01/GPOH and SIOP 2001/GPOH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

The contribution of chest CT-scan at diagnosis in children with unilateral Wilms' tumour. Results of the SIOP 2001 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Bilateral Wilms tumors (WT) treated with the SIOP 93 protocol in France: epidemiological survey and patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Synchronous bilateral Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Long-term outcome of bilateral Wilms tumors (BWT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Treatment of relapsed Wilms tumors: lessons learned.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Biology and treatment of renal tumours in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Management of adults with Wilms' tumor: recommendations based on international consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Adult Wilms' tumor: A monoinstitutional experience and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Nephroblastoma: does the decrease in tumor volume under preoperative chemotherapy predict the lymph nodes status at surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Current concepts in surgery for Wilms tumor--the risk and function-adapted strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Malignant renal tumours incidence and survival in European children (1978–1997): Report from the Automated Childhood Cancer Information System project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Treatment of Pulmonary Metastases in Children With Stage IV Nephroblastoma With Risk-Based Use of Pulmonary Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Wilms' Tumor in Adults: Results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Paediatric renal tumours: perspectives from the SIOP-RTSG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

The treatment of Wilms' Tumor: Results of the second national Wilms' Tumor study

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

31 March 2020

https://pubmed.ncbi.nlm.nih.gov/29089605

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93 01 experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Abdominal recurrences in Wilms' tumours: a report from the SIOP Wilms' tumour trials and studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

Pencil beam scanning proton therapy for treatment of the retroperitoneum after nephrectomy for Wilms tumor: A dosimetric comparison study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2017.163

31 March 2020

Identifiers

DOI

10.1038/NRUROL.2017.163

1 reference

12 February 2018

Dimensions Publication ID

0 references

1 reference

12 February 2018